CureVac’s Coronavirus Vaccine at the Center of a Fight for Control

CureVac, a German biopharmaceutical company, has hit the headlines after US President Trump tried to secure exclusive rights to its developmental coronavirus vaccine. The vaccine is being developed to prevent the spread of coronavirus (SARS-CoV-2),…
Source: Topamax